NCT05123482: A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 460 planned
- Started
- 18 Oct 2021
- Primary completion
- 29 Sep 2027
- Arms
- Sub-Study 1 AZD8205 Monotherapy
- Results
- None posted
- 18 Oct 2021: Trial started
- 17 Nov 2021: Trial registered